Enhanced Multi-Channel RF Ablation System with Advanced Signal Generation
Legal Citation
Summary of the Inventive Concept
An improved multi-channel RF ablation system that utilizes advanced signal generation techniques, including machine learning and neural networks, to optimize the ablation process, providing enhanced safety, efficiency, and effectiveness.
Background and Problem Solved
The original patent for multi-channel RF ablation (U.S. Pat. No. 9,005,193) has limitations in terms of signal generation and application. The present inventive concept addresses these limitations by introducing advanced signal generation techniques, such as machine learning and neural networks, to optimize the ablation process and provide improved safety, efficiency, and effectiveness.
Detailed Description of the Inventive Concept
The enhanced multi-channel RF ablation system comprises a controller that generates a plurality of control signals having different respective frequencies and amplitudes, using machine learning or neural networks to predict optimal ablation parameters. The system also includes a plurality of electrodes configured to apply composite signals to a subject, produced by adding the control signals to respective ablation signals having a common frequency and phase. This advanced signal generation technique enables real-time optimization of the ablation process, reducing the risk of complications and improving treatment outcomes.
Novelty and Inventive Step
The use of machine learning and neural networks to generate control signals and optimize the ablation process is a novel and non-obvious advancement over the original patent, providing a significant improvement in safety, efficiency, and effectiveness.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may include the use of other advanced signal generation techniques, such as adaptive filtering or real-time impedance monitoring, to further optimize the ablation process. Additionally, the system may be modified to accommodate different types of electrodes or ablation signals, expanding its applicability to various medical procedures.
Potential Commercial Applications and Market
The enhanced multi-channel RF ablation system has significant commercial potential in the medical device industry, particularly in the treatment of cardiac arrhythmias and other electrophysiology applications. The system's improved safety, efficiency, and effectiveness make it an attractive solution for hospitals and medical centers, with a potential market size of millions of dollars.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B18/1206 |
| A | A61 | A61B18/1492 |
| A | A61 | A61B2018/00351 |
| A | A61 | A61B2018/00577 |
| A | A61 | A61B2018/00702 |
| A | A61 | A61B2018/00732 |
| A | A61 | A61B2018/00767 |
| A | A61 | A61B2018/00791 |
| A | A61 | A61B2018/00827 |
| A | A61 | A61B2018/00875 |
| A | A61 | A61B2018/00892 |
| A | A61 | A61B2018/128 |
| A | A61 | A61B2018/1273 |
Original Patent Information
| Patent Number | US 11,857,245 |
|---|---|
| Title | Multi-channel RF ablation |
| Assignee(s) | Biosense Webster (Israel) Ltd. |